Research ExplorerPublicationsPrognosis in patients with MDS or AML and bone marrow blasts...

Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.

Standard

Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics. / Bacher, Ulrike; Kern, W; Alpermann, T; Schnittger, S; Kohlmann, A; Klein, H-U; Dugas, M; Haferlach, C; Haferlach, T.

In: LEUKEMIA, Vol. 25, No. 8, 8, 2011, p. 1361-1364.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Bacher, U, Kern, W, Alpermann, T, Schnittger, S, Kohlmann, A, Klein, H-U, Dugas, M, Haferlach, C & Haferlach, T 2011, 'Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.', LEUKEMIA, vol. 25, no. 8, 8, pp. 1361-1364. <http://www.ncbi.nlm.nih.gov/pubmed/21494258?dopt=Citation>

APA

Bacher, U., Kern, W., Alpermann, T., Schnittger, S., Kohlmann, A., Klein, H-U., Dugas, M., Haferlach, C., & Haferlach, T. (2011). Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics. LEUKEMIA, 25(8), 1361-1364. [8]. http://www.ncbi.nlm.nih.gov/pubmed/21494258?dopt=Citation

Vancouver

Bacher U, Kern W, Alpermann T, Schnittger S, Kohlmann A, Klein H-U et al. Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics. LEUKEMIA. 2011;25(8):1361-1364. 8.

Bibtex

@article{f8dc5f9ec3774a6dbc5acd420008b2da,
title = "Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Prognosis, Nuclear Proteins/genetics, Blast Crisis/*pathology, Cytogenetics, Leukemia, Myeloid, Acute/genetics/mortality/pathology, Myelodysplastic Syndromes/genetics/mortality/pathology, Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Prognosis, Nuclear Proteins/genetics, Blast Crisis/*pathology, Cytogenetics, Leukemia, Myeloid, Acute/genetics/mortality/pathology, Myelodysplastic Syndromes/genetics/mortality/pathology",
author = "Ulrike Bacher and W Kern and T Alpermann and S Schnittger and A Kohlmann and H-U Klein and M Dugas and C Haferlach and T Haferlach",
year = "2011",
language = "English",
volume = "25",
pages = "1361--1364",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "8",

}

RIS

TY - JOUR

T1 - Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.

AU - Bacher, Ulrike

AU - Kern, W

AU - Alpermann, T

AU - Schnittger, S

AU - Kohlmann, A

AU - Klein, H-U

AU - Dugas, M

AU - Haferlach, C

AU - Haferlach, T

PY - 2011

Y1 - 2011

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Prognosis

KW - Nuclear Proteins/genetics

KW - Blast Crisis/pathology

KW - Cytogenetics

KW - Leukemia, Myeloid, Acute/genetics/mortality/pathology

KW - Myelodysplastic Syndromes/genetics/mortality/pathology

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Prognosis

KW - Nuclear Proteins/genetics

KW - Blast Crisis/pathology

KW - Cytogenetics

KW - Leukemia, Myeloid, Acute/genetics/mortality/pathology

KW - Myelodysplastic Syndromes/genetics/mortality/pathology

M3 - SCORING: Journal article

VL - 25

SP - 1361

EP - 1364

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 8

M1 - 8

ER -